{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Insulet Corporation"},"Symbol":{"label":"Symbol","value":"PODD"},"Address":{"label":"Address","value":"100 NAGOG PARK, ACTON, Massachusetts, 01720, United States"},"Phone":{"label":"Phone","value":"+1 978 600-7000"},"Industry":{"label":"Industry","value":"Medical/Dental Instruments"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 150,000 insulin-dependent diabetics are using it worldwide."},"CompanyUrl":{"label":"Company Url","value":"https://www.insulet.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"James R. Hollingshead","title":"President, Chief Executive Officer & Director"},{"name":"Mark Field","title":"Chief Technology Officer"},{"name":"Prem Singh","title":"Senior Vice President-Global Operations"},{"name":"Trang Ly","title":"Senior Vice President & Medical Director"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}